Delivery Order SPE2DB22D1017-SPE2DB25FE9QW

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,579.05 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of December 27, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award, valued at $27,796.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product, and has a firm fixed-price pricing type with an ultimate completion date of November 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,579.81 Firm Fixed Price Delivery Order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $72,309.85 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,382.83 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. The contract has an ultimate completion date of July 25, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,770.43 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,055.16 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The contract has an ultimate completion date of February 25, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,706.82 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,392.34 firm fixed-price delivery order contract is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The contract has an ultimate completion date of November 25, 2024 and was awarded on November 22, 2024. This contract is not designated as a set-aside and appears to be part of a larger...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $108,347.29 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a specialty medication. The award has a period of performance ending on September 30, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE9QW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,327.82 firm-fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET in quantities of 30 tablets. The contract has an ultimate completion date of November 22, 2024.

This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 2/20/25, 9:36 AM